from2015-istockphoto-com-report-1

from2015 / iStockphoto.com

31 August 2018Americas

Massachusetts biotech companies ‘dominate’ industry IPOs: report

A report released this week by non-profit MassBio has shown that Massachusetts companies “dominated” the landscape for US initial public offerings (IPOs) of biotech companies in 2017.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers